1 / 61

Protein Synthesis Inhibitors

Protein Synthesis Inhibitors. BY S.Bohlooli , PhD School of Medicine, Ardabil University of Medical Sciences. Protein Synthesis Inhibitors. Tetracyclines Amimoglycosides Macrolides Clindamycin Chloramphenicol Streptogramines Oxazolidinones. Tetracycline.

darva
Download Presentation

Protein Synthesis Inhibitors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Protein Synthesis Inhibitors BY S.Bohlooli, PhD School of Medicine, Ardabil University of Medical Sciences

  2. Protein Synthesis Inhibitors • Tetracyclines • Amimoglycosides • Macrolides • Clindamycin • Chloramphenicol • Streptogramines • Oxazolidinones

  3. Tetracycline • First compound, chlortetracycline introduced in 1948 • Highly effective against rickettsiae, gm + and – bacteria, chlamydia • Inhibit protein synthesis by reversibly binding to 30 S subunit of bacterial ribosome, preventing binding of aminoacyl tRNA to mRNA ribosomal complex • Bacteriostatic

  4. Chemical Structure

  5. Chemical Structure

  6. Inhibition of bacterial protein synthesis by tetracyclines.

  7. Resistance • Wide resistance limits clinical uses • Most penicillinase-producing staphylococci are resistant

  8. Absorption • Incomplete GI absorption: tetracycline (60-80%), doxycycline (95%), minocycline (100%) • Dairy foods decrease absorption by forming nonabsorbable chelates with calcium ions; also Mg, Fe, Al (antacids)

  9. Distribution • Widely distributed in body • Bind in tissues undergoing calcification (teeth, bones) or tumors with high calcium content (gastric carcinoma) • All cross placenta and concentrate in fetal bones and teeth • Minocycline best CSF penetration • Concentrated in saliva and gingival fluid

  10. Excretion • Concentrate in liver and partially metabolized • Secreted into bile and excreted in urine • Doxycycline and minocycline largely excreted in feces • Use in renal insufficiency

  11. General Therapeutic Uses • Lyme disease • Spirochete (Borelia burgdorferi) tick bite • Skin lesions, headache, fever, meningioencephalitis, arthritis • Mycoplasma pneumonia • Young adult pneumonia • Rocky mountain spotted fever • Fever, chills, bone and joint aches • Acne

  12. General Therapeutic Uses • Chlamydia • Lymphogranuloma venereum- lymph node hypertrophy, obstruction, elephantiasis • Psittacosis- pneumonia, hepatitis, myocarditis, coma • Cholera • Ingested fecally contaminated food or water • Organism multiplies in GI tract and secretes enterotoxin producing diarrhea • Doxycycline reduces organism • Fluid replacement

  13. Adverse Effects • GI discomfort • Anorexia, epigastric pain, abdominal distention, nausea, vomiting, diarrhea, sore mouth, perianal irritation • Hepatic injury • Increased during pregnancy • Nephrotoxicity

  14. Adverse Effects • Teeth • Discoloration enamel and hypoplasia of teeth • Depression of bone growth • Deposition in fetal and growing bones, stunted growth • Photosensitization • Severe sunburn in sun; doxy/demeclocycline • Superinfections • Candida or GI staphylococcus

  15. Contraindications • Pregnancy • Children • Renal insufficiency • Can use doxycycline

  16. Drug Interactions • Do not give with other antibiotics unless establish synergy • Increased effects of anticoagulants • Not absorbed by cations like Ca, Mg, Fe, Al • H2 blockers may depress tetracycline uptake

  17. Aminoglycosides • Contain amino sugars linked to aminocyclitol by glycosidic bonds • Binds to 30 S ribosomal subunit (streptomycin) or 50 S (gent/others), interfering with assembly of functional ribosomal apparatus or misreading of genetic code • Aerobic gram negative bacteria • Bactericidal or static

  18. Resistance • Decreased uptake • Absent oxygen-dependent transport • Altered receptor • 30S ribosomal subunit binding site has lower affinity for aminoglycosides • Enzymatic modification • Plasmid R factors that synthesize enzymes to modify and inactivate antibiotic

  19. Administration • Inadequate absorption when oral • All parenteral, except neomycin • Neomycin • Severe nephrotoxicity • Only topical use to reduce intestinal bacteria

  20. Distribution • Good body fluid penetration, except CSF • Accumulation in renal cortex and inner ear lymph • All cross placenta

  21. Metabolism • Rapidly excreted into urine • Alter dose in renal insufficiency

  22. General Therapeutic Uses • Streptomycin • Bacterial endocarditis (+ Pen) • Tuberculosis (combination) • Tularemia- hunters skinning infected animals • Gentamycin: combination with Pen/Ceph • Urinary tract infections (E coli, enterobacter) • Pneumonia (pseudomonas, E coli, kleb) • Meningitis • Peritonitis

  23. General Therapeutic Uses • Tobramycin • Same as gentamycin • Poor activity against enterococci • Amikacin • Initial treatment of serious nosocomial gram negative bacilli infections when resistance to gentamycin and tobramycin

  24. General Therapeutic Uses • Netilmicin • Serious infections with enterobacteriaceae and other aerobic gram negative bacilli • Kanamycin • Few indications • Neomycin • Topical skin and mucosa infections

  25. Adverse Effects • Ototoxicity • High peak levels and long duration • Nephrotoxicity • Neuromuscular paralysis • Intraperitoneal/intrapleural high dose; myasthenia gravis patients at risk • Contact dermatitis- neomycin topical • Monitor peak and trough plasma levels

  26. Macrolides • Many membered lactone ring where sugars or amino acids are attached • Erythromycin • Azithromycin • Clarithromycin- more strep and staph • Dirithromycin • Troleandomycin • Telithromycin

  27. Mechanism of Action • Bind to 50 S subunit of bacterial ribosome, inhibiting translocation step of protein synthesis • Bacteriostatic activity • Better intracellular concentration with gram + bacteria • Clarithro and Azithro more anaerobic

  28. Inhibition of bacterial protein synthesis by the macrolide antibiotics erythromycin, clarithromycin, and azithromycin

  29. Resistance • Inability of organism to take up antibiotic • Decreased affinity of binding site for antibiotic

  30. Administration • Adequate oral absorption • Intravenous: thrombophlebitis • Intramuscular: painful

  31. Distribution • Well into body fluids, except CSF • Diffuses into prostatic fluids • Accumulates in macrophages • Concentrated in liver • Penetrate well into abscesses

  32. Metabolism • Inhibits oxidation of other drugs through interaction with cytochrome P-450 system

  33. Excretion • Concentrated and excreted in an active form in the bile • Partial reabsorption through enterohepatic circulation

  34. General Therapeutic Uses • Mycoplasma pneumonia • Syphilis- in penicillin allergic • Chlamydia- alternative to tetracycline; during pregnancy • Legionellosis pneumonia • Corynebacterium diptheriae- carriers • Ureaplasma- urethritis

  35. General Therapeutic Uses • Alternative to penicillin in allergic patients • Clarithromycin (Biaxin) and Azythromycin (Zithromax) • COPD, pneumonia • Pharyngitis, tonsillitis • Acute maxillary sinusitis • Lower respiratory tract infections

  36. Adverse Effects • Epigastric distress • Nausea, vomiting, pain, diarrhea • Cholestatic jaundice • When estolate form is used • Ototoxicity • High doses

  37. Interactions • Increases plasma concentration of digoxin • Inhibits hepatic metabolism of drugs • Theophylin • Warfarin • Carbamazepine • Cyclosporin • Methylprednisolone • Terfenadine • Do not use in liver disease patients

  38. Clindamycin • Introduced in 1970 • Semisynthetic derivative of lincomycin, isolated from soil near Lincoln, Nebraska in 1965 • Clindamycin produced by exchange of hydroxyl group with chlorine atom at C7 of lincomycin molecule

  39. Clindamycin • Binds to 50 S subunit of bacterial ribosomes to inhibit protein synthesis • Bacteriostatic activity, but cidal action against susceptible organisms in vivo

More Related